198 related articles for article (PubMed ID: 22521915)
21. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
22. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
23. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.
Carroll PA; Brazeau E; Lagunoff M
Virology; 2004 Oct; 328(1):7-18. PubMed ID: 15380353
[TBL] [Abstract][Full Text] [Related]
25. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit.
Molden J; Chang Y; You Y; Moore PS; Goldsmith MA
J Biol Chem; 1997 Aug; 272(31):19625-31. PubMed ID: 9235971
[TBL] [Abstract][Full Text] [Related]
26. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
27. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
[TBL] [Abstract][Full Text] [Related]
28. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
30. Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.
Dela Cruz CS; Viswanathan SR; El-Guindy AS; Shedd D; Miller G
J Biol Chem; 2009 Oct; 284(43):29269-82. PubMed ID: 19690161
[TBL] [Abstract][Full Text] [Related]
31. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.
Cheng F; Pekkonen P; Laurinavicius S; Sugiyama N; Henderson S; Günther T; Rantanen V; Kaivanto E; Aavikko M; Sarek G; Hautaniemi S; Biberfeld P; Aaltonen L; Grundhoff A; Boshoff C; Alitalo K; Lehti K; Ojala PM
Cell Host Microbe; 2011 Dec; 10(6):577-90. PubMed ID: 22177562
[TBL] [Abstract][Full Text] [Related]
32. Effects of Kaposi's sarcoma-associated herpesvirus ORF K1 on differentiating endothelium in murine embryoid bodies and teratomas.
Mebrahtu S; Eriksson U; Rauch U; Warenholt J; Bendsöe N; Dictor M
Exp Cell Res; 2004 Jan; 292(2):322-31. PubMed ID: 14697340
[TBL] [Abstract][Full Text] [Related]
33. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
[TBL] [Abstract][Full Text] [Related]
35. KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells.
DiMaio TA; Vogt DT; Lagunoff M
PLoS Pathog; 2020 Jun; 16(6):e1008634. PubMed ID: 32555637
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
[TBL] [Abstract][Full Text] [Related]
37. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.
Hansen A; Henderson S; Lagos D; Nikitenko L; Coulter E; Roberts S; Gratrix F; Plaisance K; Renne R; Bower M; Kellam P; Boshoff C
Genes Dev; 2010 Jan; 24(2):195-205. PubMed ID: 20080955
[TBL] [Abstract][Full Text] [Related]
38. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
Abere B; Schulz TF
Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
[TBL] [Abstract][Full Text] [Related]
39. KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi's sarcoma studies.
Tuohinto K; DiMaio TA; Kiss EA; Laakkonen P; Saharinen P; Karnezis T; Lagunoff M; Ojala PM
PLoS Pathog; 2023 Jan; 19(1):e1010753. PubMed ID: 36689549
[TBL] [Abstract][Full Text] [Related]
40. KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression.
Gilardini Montani MS; Falcinelli L; Santarelli R; Granato M; Romeo MA; Cecere N; Gonnella R; D'Orazi G; Faggioni A; Cirone M
Br J Cancer; 2020 Jul; 123(2):298-306. PubMed ID: 32418990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
